Home
News
Tech
Finance
Leadership
Well
Recommends
Fortune 500
Home Page
Already have an account?
SIGN IN
SEARCH
Subscribe Now
Sections
FORTUNE 500
News
Europe
Asia
Tech
AI
Finance
Personal Finance
Real Estate
Crypto
Leadership
Success
Well
Life
Health
Mind
Family
Aging Well
Recommends
Credit Cards
Banking
Best High-Yield Savings Accounts
Best Savings Accounts
Best CD Rates
Best Money Market Accounts
Savings Calculator
Insurance
Mortgages
Investing
Loans
Health
Education
Top Business Schools
Top Information Technology and Data Schools
Top Health Schools
Business Solutions
Video
Rankings
FORTUNE 500
GLOBAL 500
MOST POWERFUL WOMEN
GREAT PLACE TO WORK LISTS
BEST MBA PROGRAMS
MORE RANKINGS
Analytics
Newsletters
Magazine
December 2023/January 2024
October/November 2023
August/September 2023
June/July 2023
April/May 2023
February/March 2023
Live Media
CEO Initiative
Naomi Kresge
Health
A rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails
BY
Naomi Kresge
and
Bloomberg
Health
EU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics
BY
Naomi Kresge
and
Bloomberg
Health
Novo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project
BY
Naomi Kresge
and
Bloomberg
Finance
Germany just offloaded $2.7 billion in one of its largest companies so it can bolster its railway networks
BY
Swetha Gopinath
,
Naomi Kresge
, and others
Retail
Danish pharma giant Novo Nordisk’s office building is in danger of collapsing after a ‘massive fire’ broke out
BY
Sanne Wass
,
Naomi Kresge
, and others
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
BY
Naomi Kresge
and
Bloomberg
Retail
Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
BY
Sanne Wass
,
Naomi Kresge
, and others
Health
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
BY
Naomi Kresge
and
Bloomberg
Health
A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says
BY
Naomi Kresge
,
Angela Feliciano
, and others
Health
A ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’
BY
Madison Muller
,
Naomi Kresge
, and others
Health
Roche is using AI to find the hardest-to-find lung cancer patients, with a potential blockbuster drug on the line
BY
Naomi Kresge
and
Bloomberg
Health
COVID vaccine scientists claim Nobel Prize in medicine
BY
Naomi Kresge
,
Kati Pohjanpalo
, and others
Health
Taking new weight-loss drug Wegovy by pill is just as effective as a shot, study finds
BY
Naomi Kresge
and
Bloomberg
Health
Taking diet drug Wegovy for a year comes with a major added benefit, study finds
BY
Naomi Kresge
and
Bloomberg
Health
Arthritis drug reduced risk of COVID deaths by 13%, U.K. study finds
BY
Naomi Kresge
and
Bloomberg
Load More